戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s, which may give rise to disease-associated repeat expansion.
2 0.2) years, and 37 of them carried a C9ORF72 repeat expansion.
3 cases with FECD (69.7%) harbored the triplet repeat expansion.
4 ntingtin protein (mHTT) with a polyglutamine-repeat expansion.
5 ical/neuromuscular disease associated with a repeat expansion.
6 various models of FTD/ALS with GGGGCC (G4C2) repeat expansion.
7 imilar cells from FECD patients who lack the repeat expansion.
8 lly targeted to the newly discovered C9orf72 repeat expansion.
9 er resulted in prevention and attenuation of repeat expansion.
10  important implications for the mechanism of repeat expansion.
11         Two individuals harbored the C9ORF72 repeat expansion.
12 rotein-coding sequence evolved through a CAG repeat expansion.
13 ify candidate binding partners of the GGGGCC repeat expansion.
14  hairpin can remove the hairpin, attenuating repeat expansion.
15 NA silencing of MSH2 impeded CTG.CAG triplet-repeat expansion.
16 hesis is considered a major path for CAG/CTG repeat expansion.
17  mutations, that is, IT15 gene trinucleotide-repeat expansion.
18 generative disorder cause by a trinucleotide repeat expansion.
19 ide polymorphisms (SNPs) associated with the repeat expansion.
20 ta, thereby leading to hairpin retention and repeat expansion.
21 8.95%) of 4925 ALS cases carried the C9orf72 repeat expansion.
22 reover, longer repeats showed faster triplet-repeat expansion.
23 ects) were shown to carry the hexanucleotide repeat expansion.
24 second-degree relatives) carried the C9orf72 repeat expansion.
25                  HDL2 is caused by a CTG/CAG repeat expansion.
26 and MSH3, is known to have a role in CAG.CTG repeat expansion.
27 esymptomatic individuals who carry a C9orf72 repeat expansion.
28  confirming a proposed mechanism for triplet repeat expansion.
29 h frontotemporal dementia due to the C9orf72 repeat expansion.
30 ion, identifying a role for recombination in repeat expansion.
31 nction, with the inherent risk of pathogenic repeat expansions.
32 d correctly flagged all but one of the known repeat expansions.
33 families showed large C9orf72 hexanucleotide repeat expansions.
34 unconventional initiation at disease-causing repeat expansions.
35 ess of 30 were considered to have pathogenic repeat expansions.
36 by flap endonuclease 1 (FEN1) to mediate CAG repeat expansions.
37 ty of clinical presentations associated with repeat expansions.
38 beta on during DNA synthesis induces CAG/CTG repeat expansions.
39  that can be used to identify new pathogenic repeat expansions.
40 mples carrying chromosome 9 ORF 72 (C9orf72) repeat expansions.
41 ] per additional year; p=0.0476), and longer repeat expansions (0.06 [SE 0.02] per additional repeat
42            Forty-seven participants with the repeat expansion (55.3%) had undergone keratoplasty at t
43                              Premutation CGG repeat expansions (55-200 CGG repeats; preCGG) within th
44                              Premutation CGG repeat expansions (55-200 CGG repeats; preCGG) within th
45 i Peninsula ALS cases had pathogenic C9orf72 repeat expansions, a genotype that causes ALS in Western
46 m of mental retardation, a CGG trinucleotide-repeat expansion adjacent to the fragile X mental retard
47 der that affects carriers of premutation CGG-repeat expansion alleles of the fragile X mental retarda
48                                              Repeat expansions, also present in other neurodegenerati
49  incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls w
50 sis (ALS), including carriers of the C9orf72 repeat expansion and C9orf72-negative sporadic cases.
51 within this region, we measured the rates of repeat expansion and contraction using novel reporters a
52 strains), suggesting a balancing act between repeat expansion and contraction.
53 ificity may require a similar combination of repeat expansion and tailored amino acid variation.
54 ts, together with the C9orf72 hexanucleotide repeat expansions and a copy number gain of APP, were fo
55     The increased length results from tandem repeat expansions and an unusual 13 kb IR-SSC boundary s
56                                         Both repeat expansions and contractions are observed, and rep
57 s, small indels (10-50 bp), and short tandem repeat expansions and contractions.
58 t strands to prevent recombination-dependent repeat expansions and contractions.
59 repair protein function in mediating triplet repeat expansions and discuss potential therapeutic appr
60 e used to accurately detect known pathogenic repeat expansions and provides researchers with a tool t
61 D and highlights the importance of noncoding repeat expansions and RNA toxicity in neurodegenerative
62  the 'stem/progenitor' cells that allow this repeated expansion and renewal.
63 n relatives of ALS patients with the C9orf72 repeat expansion, and 2.3 (p=0.019) in relatives of ALS
64  were required to prevent Rad5-dependent CAG repeat expansions, and H4K16 acetylation was enriched at
65 owever, it is unclear whether the effects of repeat expansion are unique to these specific sequences
66                                       Longer repeat expansions are associated with genetic anticipati
67                                        These repeat expansions are currently the most important genet
68    Clinical phenotypes associated with these repeat expansions are highly variable, and combinations
69                       C9orf72 hexanucleotide repeat expansions are the most common cause of familial
70 configurational slippage that often leads to repeat expansion associated with neurological diseases.
71                        HFMs carry a full CGG repeat expansion but exhibit an unmethylated promoter an
72 o determined that RAD52 is necessary for CTD repeat expansion but not contraction, identifying a role
73 -/- cells are severely defective for CTG*CAG repeat expansions but show full activity on contractions
74 t is pronounced in kindreds with the C9orf72 repeat expansion, but is also present in kindreds of tho
75  anticipation in families carrying a C9orf72 repeat expansion by analyzing age at onset, disease dura
76  anticipation in families carrying a C9orf72 repeat expansion by means of a decrease in age at onset
77 mined the presence or absence of the C9orf72 repeat expansion by repeat-primed polymerase chain react
78    Recent studies have demonstrated that CAG repeat expansions can be initiated by oxidative DNA base
79                                   Nucleotide repeat expansions can elicit neurodegeneration as RNA by
80 her polyglutamine diseases, suggest that CAG repeat expansions can promote aberrant splicing to produ
81 rons transdifferentiated from fibroblasts of repeat expansion carriers.
82 otype with disease, and clinical features of repeat expansion carriers.
83                                      CTG*CAG repeat expansions cause at least twelve inherited neurol
84                                              Repeat expansions cause dominantly inherited neurologica
85 by unconventional translation of the C9orf72 repeat expansions cause neurodegeneration in cell cultur
86                It has been reported that the repeat expansion causes a downregulation of C9orf72 tran
87  grade was 5.61 (0.76) in the group with the repeat expansion compared with 5.11 (1.05) in the group
88 mer Disease Family Study series, the C9orf72 repeat expansions constituted the second most common pat
89 is unknown, as is the mechanism by which the repeat expansion could cause disease.
90                            Here we show that repeat expansions create templates for multivalent base-
91 ating interaction between gender and C9orf72 repeat expansions demonstrated that the reduced survival
92 O) therapeutics to the C9ORF72 transcript or repeat expansion despite the presence of repeat-associat
93 umina HumanOmniExpress-12 BeadChip); C9orf72 repeat expansion detection; and APOE genotyping.
94 echanism by which the C9orf72 hexanucleotide repeat expansion directs C9ALS/FTD pathogenesis remains
95           Fragile X-associated disorders are Repeat Expansion Diseases that result from expansion of
96 tes termed RNA foci, a hallmark of noncoding repeat expansion diseases, have been shown to sequester
97  the neuron death observed in the nucleotide repeat expansion diseases.
98 Epigenetic gene silencing is seen in several repeat-expansion diseases.
99 a convergence of pathogenic cascades between repeat expansion disorders and RNA-binding proteins impl
100  genetic disease (monogenic, epigenetic, and repeat expansion disorders), and the approach to therapy
101 glutamine diseases and could extend to other repeat expansion disorders.
102 the most prevalent member of a family of CAG repeat expansion disorders.
103                       Ten cases with C9orf72 repeat expansion displayed the same sequential spreading
104                  The presence of the C9orf72 repeat expansion does not fully account for this finding
105 on of C9ORF72 and the mechanism by which the repeat expansion drives neuropathology are unknown.
106       These findings support a model whereby repeat expansions elicit cellular stress conditions that
107 l neurodegenerative disorder caused by a CAG repeat expansion encoding a polyglutamine tract in the h
108 opulation with this (CTG.CAG)n trinucleotide repeat expansion exceeds that of the combined number of
109                                      C9orf72 repeat expansions explain a small proportion of patients
110 an cellular model that recapitulates the DNA repeat expansion found in FRDA patient tissues.
111                                          GAC repeat expansion from five to seven in the exonic region
112 2, ATXN3, ATXN7, TBP and CACNA1A and the CAG repeat expansion gene PPP2R2B.
113                    INTRODUCTION: The C9orf72 repeat expansion has been reported as a negative prognos
114                                  The C9orf72 repeat expansion has been reported as a negative prognos
115 eporter construct models for GAA.TTC triplet-repeat expansion have been reported, studies on FRDA pat
116                                      C9ORF72 repeat expansions have a primary role in increasing the
117                                              Repeat expansions have also been detected infrequently i
118                Tetranucleotide TTTA and CCTG repeat expansions have been known to cause reduction in
119 rodegenerative diseases caused by nucleotide repeat expansion, have highlighted or identified two for
120                             A hexanucleotide repeat expansion (HRE), (GGGGCC)n, in C9orf72 is the mos
121 his case-control study genotyped the C9orf72 repeat expansion in 872 unrelated familial AD cases and
122                            The GGGGCC (G4C2) repeat expansion in a noncoding region of C9orf72 is the
123        To elucidate the consequences of G4C2 repeat expansion in a tractable genetic system, we gener
124 mark discovery of the C9ORF72 hexanucleotide repeat expansion in ALS/FTD, a transgenic mouse model ha
125                                Polyglutamine repeat expansion in ataxin-3 causes neurodegeneration in
126  the CpG island located at the 5' end of the repeat expansion in blood, frontal cortex, and spinal co
127 s may be especially true for ALS caused by a repeat expansion in C9orf72 (c9ALS), in which the accumu
128                                            A repeat expansion in C9ORF72 causes frontotemporal dement
129 urons produced from ALS patients harboring a repeat expansion in C9orf72 indicates that at least a su
130                                 The G(4)C(2)-repeat expansion in C9orf72 is a common cause of frontot
131                                          The repeat expansion in C9ORF72 is a common cause of FTLD an
132                   A noncoding hexanucleotide repeat expansion in C9orf72 is the most common cause of
133                                    A (G4C2)n repeat expansion in C9ORF72 is the most common genetic c
134 ENTIFIC COMMENTARY ON THIS ARTICLE: A GGGGCC repeat expansion in C9orf72 leads to frontotemporal deme
135                               Hexanucleotide repeat expansion in C9orf72 represents the most common g
136                                  Recently, a repeat expansion in C9orf72 was identified as the causal
137         Since the discovery that a noncoding repeat expansion in C9orf72 was responsible for chromoso
138  and amyotrophic lateral sclerosis is a G4C2 repeat expansion in C9ORF72.
139    We have addressed the genetics of CAG.CTG repeat expansion in E. coli and shown that these repeat
140 xamined the prognostic impact of the C9orf72 repeat expansion in European subgroups based on gender a
141                        It is caused by a CAG repeat expansion in exon 1 of the HTT gene that translat
142 with high-throughput sequencing that the GAA-repeat expansion in FRDA cells stimulates a higher-order
143 polymorphism (SNP) variant that is linked to repeat expansion in haplogroup D and a replication origi
144 is determined largely by the length of a CAG repeat expansion in HTT but is also influenced by other
145 ty-eight patients carried a pathological CAG repeat expansion in HTT, whereas 28 patients (12 women a
146  reflects the dominant consequences of a CAG-repeat expansion in HTT.
147 a multisystemic disorder caused by a (CCTG)n repeat expansion in intron 1 of CNBP.
148                  A non-coding hexanucleotide repeat expansion in intron 1 of the C9orf72 gene is the
149  insight into a general mechanism of triplet-repeat expansion in iPSCs.
150                          The CTG18.1 triplet repeat expansion in TCF4 has recently been found to be a
151 eater in FECD cases with the CTG18.1 triplet repeat expansion in TCF4 than in those without the expan
152 ondition, resulting from a CGG trinucleotide repeat expansion in the 5' leader sequence of the FMR1 g
153 r ataxia syndrome (FXTAS) results from a CGG repeat expansion in the 5' UTR of FMR1.
154 ative disorder caused by a CGG trinucleotide repeat expansion in the 5' UTR of the Fragile X gene, FM
155                                 A 55-200 CGG repeat expansion in the 5'-UTR of the fragile X mental r
156 ciated tremor/ataxia syndrome (FXTAS), a CGG repeat expansion in the 5'UTR of the fragile X gene (FMR
157 nked motoneuron disease due to a CAG triplet-repeat expansion in the androgen receptor (AR) gene, whi
158 rder caused by a CAG - polyglutamine (polyQ) repeat expansion in the ataxin-7 gene.
159 nant neurodegenerative disease caused by CAG repeat expansion in the ATXN2 gene.
160 order caused by a polyglutamine-encoding CAG repeat expansion in the ATXN3 gene.
161                               Hexanucleotide repeat expansion in the bi-directionally transcribed C9o
162 PRn) poly-dipeptide encoded by the (GGGGCC)n repeat expansion in the C9orf72 form of heritable amyotr
163       The identification of a hexanucleotide repeat expansion in the C9ORF72 gene as the cause of chr
164                      A GGGGCC hexanucleotide repeat expansion in the C9orf72 gene is the most common
165                  A non-coding hexanucleotide repeat expansion in the C9ORF72 gene is the most common
166                                  A noncoding repeat expansion in the C9orf72 gene is the most common
167                             A hexanucleotide repeat expansion in the C9orf72 gene is the most common
168 d recent findings show that a hexanucleotide repeat expansion in the C9ORF72 gene may account for >30
169 neration, was found to have a hexanucleotide repeat expansion in the C9ORF72 gene.
170  finding that a GGGGCC (G4C2) hexanucleotide repeat expansion in the chromosome 9 ORF 72 (C9ORF72) ge
171  disorder caused by a trinucleotide (CAG)(n) repeat expansion in the coding sequence of the huntingti
172                        Polyglutamine (polyQ) repeat expansion in the deubiquitinase ataxin-3 causes n
173 ost prevalent of these mutations is a GGGGCC repeat expansion in the first intron of C9ORF72 As shown
174                             A hexanucleotide repeat expansion in the first intron of C9ORF72 has been
175 f the TARDBP gene or a GGGGCC hexanucleotide repeat expansion in the first intron of the C9ORF72 gene
176  Fragile X syndrome (FXS) is caused by a CGG repeat expansion in the FMR1 gene that appears to occur
177 ases by homozygosity for a GAA trinucleotide repeat expansion in the frataxin gene.
178                        HD is caused by a CAG repeat expansion in the Huntingtin (HTT) gene, translati
179 ative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene, which enc
180                        HD is caused by a CAG repeat expansion in the huntingtin (HTT) gene, while HDL
181 Huntington's disease (HD) is caused by a CAG repeat expansion in the huntingtin (HTT) gene.
182 ative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene.
183      Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT.
184 d neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene.
185 l neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene.
186                                      The CAG repeat expansion in the Huntington's disease gene HTT ex
187 r caused by a pathological CAG trinucleotide repeat expansion in the large multi-exon gene, huntingti
188 al disorders are linked to tandem nucleotide repeat expansion in the mutated gene.
189 otonic dystrophy (DM) is caused by a triplet repeat expansion in the non-coding region of either the
190                      A hexanucleotide GGGGCC repeat expansion in the noncoding region of the C9ORF72
191            OPMD is caused by a trinucleotide repeat expansion in the PABPN1 gene that results in an N
192 ive disease caused by a pathogenic glutamine repeat expansion in the protein ataxin-1 (ATXN1).
193 is with an intronic (CTG.CAG)n trinucleotide repeat expansion in the TCF4 gene, which is found in the
194 ALS has recently been mapped to a non-coding repeat expansion in the uncharacterized gene C9ORF72.
195 ocytes cell-autonomously, we manipulated the repeat expansion in the variant SCA3 knock-in mouse by c
196 ing sequences have arisen via the process of repeat expansion in this protein.
197                      Hexanucleotide (GGGGCC) repeat expansions in a noncoding region of C9ORF72 are t
198 termined the frequency of the hexanucleotide repeat expansions in a population of 651 FTLD patients a
199       To study pathogenic mechanisms of CCUG-repeat expansions in an animal model, we created a fly m
200                               Hexanucleotide repeat expansions in C9orf72 are a major cause of fronto
201                               Hexanucleotide repeat expansions in C9orf72 are the most common cause o
202                                       GGGGCC repeat expansions in C9ORF72 are the most common genetic
203                 Patients with hexanucleotide repeat expansions in C9orf72 can present with MSA as wel
204                  How hexanucleotide (GGGGCC) repeat expansions in C9ORF72 cause amyotrophic lateral s
205                               Hexanucleotide repeat expansions in C9ORF72 cause neurodegeneration in
206                  All participants had GGGGCC repeat expansions in C9ORF72, and high quality DNA was a
207 rotein unconventionally translated from G4C2 repeat expansions in C9ORF72, are abundant in patients w
208  lateral sclerosis (ALS) with hexanucleotide repeat expansions in C9orf72.
209 neurologic presentations with hexanucleotide repeat expansions in C9orf72.
210                               Hexanucleotide repeat expansions in chromosome 9 open reading frame 72
211 large inverted segments and short nucleotide repeat expansions in diseases such as hemophilia A, frag
212                               Microsatellite repeat expansions in DNA produce pathogenic RNA species
213                                Trinucleotide repeat expansions in FMR1 abolish FMRP expression, leadi
214   Huntington disease phenocopies without CAG repeat expansions in HTT are not rare, occurring in 12.4
215  evidence for the continuous accumulation of repeat expansions in non-dividing cells.
216                    Identification of C9orf72 repeat expansions in patients without a family history o
217                  Polyglutamine-coding (CAG)n repeat expansions in seven different genes cause spinoce
218                                          CUG repeat expansions in the 3' UTR of dystrophia myotonica
219 taxia Syndrome, result from unmethylated CGG repeat expansions in the 5' untranslated region (UTR) of
220  produces toxic polypeptides from nucleotide repeat expansions in the absence of an AUG start codon a
221  SBMA is caused by CAG-polyglutamine (polyQ) repeat expansions in the androgen receptor (AR) gene.
222                               Hexanucleotide repeat expansions in the C9ORF72 gene are the commonest
223      The recent discovery that expression of repeat expansions in the C9orf72 gene may induce RNA foc
224                               Hexanucleotide repeat expansions in the chromosome 9 open reading frame
225                 Homozygous GAA trinucleotide repeat expansions in the first intron of FXN occur in 96
226 erative disorder caused by CGG trinucleotide repeat expansions in the fragile X mental retardation 1
227        Huntington's disease is caused by CAG repeat expansions in the HTT gene, which encodes the hun
228   Although dominant gain-of-function triplet repeat expansions in the Huntingtin (HTT) gene are the u
229 n vitro and large-scale trinucleotide (GAA)n repeat expansions in vivo, implying failed phosphate-ste
230     An intronic GGGGCC (G4C2) hexanucleotide repeat expansion inC9orf72 is the most common genetic ca
231 sample had one of eight different pathogenic repeat expansions, including those associated with fragi
232  a significant number of proteins, and their repeat expansion is associated with a number of genetic
233 red BRC repeat numbers, we show that the BRC repeat expansion is crucial for RAD51 subnuclear dynamic
234 most Friedreich ataxia patients, a large GAA-repeat expansion is present within the first intron of b
235 dies show that a primary consequence of G4C2 repeat expansion is the compromise of nucleocytoplasmic
236       A gain-of-function of these pathogenic repeat expansions is mediated at least in part by their
237 le DNA repair has been implicated in CAG.CTG repeat expansion, its role in the GAA.TTC expansion of F
238 d neurodegenerative disorder caused by a CAG repeat expansion leading to an elongated polyglutamine s
239                  Patients carrying a C9orf72 repeat expansion leading to frontotemporal dementia and/
240                   The C9orf72 hexanucleotide repeat expansion led to haploinsufficiency resulting in
241       This property is shared with a fly CUG-repeat expansion model.
242 was an early event in FUS as well as C9ORF72 repeat expansion models of ALS, and that serial imaging
243 (HD) reflects dominant consequences of a CAG repeat expansion mutation in HTT.
244 1 (FMR1), is silenced in most cases by a CGG-repeat expansion mutation in the 5' untranslated region
245                             A hexanucleotide repeat expansion mutation in the C9orf72 gene represents
246      Fragile X syndrome (FXS) results from a repeat expansion mutation near the FMR1 gene promoter an
247 ights into novel mechanistic pathways of DNA repeat expansion mutations.
248 be the structural intermediates that lead to repeat expansion mutations.
249 ) of a protein associated with polyglutamine repeat expansion, namely Huntingtin, and characterized i
250 apture method to determine the exact triplet repeat expansion number in the Huntington's gene of geno
251 ts with amyotrophic lateral sclerosis with a repeat expansion of C9orf72 (C9orf72+), but not from tho
252 f72+), but not from those patients without a repeat expansion of C9orf72 (C9orf72-) or control subjec
253   His father, who carried the hexanucleotide repeat expansion of C9ORF72 gene, had spinal ALS and FTD
254 tation of TARDBP gene and the hexanucleotide repeat expansion of C9ORF72 gene.
255                      A GGGGCC hexanucleotide repeat expansion of C9ORF72 has recently been identified
256                     Intermediate or full CAG repeat expansions of ATXN2 are associated with ALS.
257 er uncle with ALS have full pathological CAG repeat expansions of ATXN2.
258                                       GGGGCC repeat expansions of C9orf72 represent the most common g
259          These introns are defined by simple repeat expansions of complementary AC and GT dimers that
260 m for interaction between the pathogenic RNA repeat expansions of myotonic dystrophy and MBNL1.
261                                              Repeat expansions of this type have been associated with
262   The Arabian Margin record demonstrates the repeated expansion of ferruginous conditions with the di
263 res of the C9orf72 repeat may participate in repeat expansions or pathogenesis of amyotrophic lateral
264  in the vector with an approximately 310 GAA repeat expansion (pBAC-FXN-GAA-Luc).
265         Patients with C9ORF72 hexanucleotide repeat expansions present some phenotypic differences co
266                     The discovery of C9ORF72 repeat expansions provides novel insights into the patho
267  DM2 that expresses pure, uninterrupted CCUG-repeat expansions ranging from 16 to 720 repeats in leng
268                               Hexanucleotide repeat expansions represent the most common genetic caus
269 ading frame 72 (c9orf72) gene hexanucleotide repeat expansion represents a major advance in the under
270                             The TCF4 triplet repeat expansion resulted in a more severe form of FECD,
271  and efficient elimination of microsatellite repeat expansion RNAs both when exogenously expressed an
272 C9(+)] patients, and antisense GGCCCC (G2C4) repeat-expansion RNAs accumulate in nuclear foci in brai
273 r structure as a fragment containing the GAA-repeat expansion showed an increased interaction frequen
274 s (DPRs) derived from C9orf72 hexanucleotide repeat expansions similarly undergo LLPS and induce phas
275          HD is caused by a trinucleotide CAG repeat expansion that encodes a polyglutamine stretch in
276    Fragile X syndrome (FXS) is caused by CGG repeat expansion that leads to FMR1 silencing.
277      Here we analyze RAN translation at G4C2 repeat expansions that cause C9orf72-associated amyotrop
278 ir has been implicated as a cause of triplet repeat expansions that cause neurological diseases such
279 llar ataxia type 3 (SCA3), are caused by CAG repeat expansions that encode abnormally long glutamine
280            Thus, our data link trinucleotide-repeat expansion to a form of RNA-directed gene silencin
281 n through the repeats, which could result in repeat expansion to the FXS full mutation.
282  were targeted to the C9orf72 hexanucleotide repeat expansion to upregulate normal variant 1 transcri
283                      These non-coding tandem repeat expansions trigger the production of unusual RNAs
284 omosomal rearrangements and short nucleotide repeat expansions using engineered nucleases in human in
285 m symptom onset among cases carrying C9ORF72 repeat expansion was 3.2 years lower than that of patien
286                               The pathogenic repeat expansion was detected in 39 (6%) patients with F
287                              The CACNA1A CAG repeat expansion was excluded.
288 extended Belgian families in which a C9orf72 repeat expansion was segregating.
289 logistic regression, the presence of C9ORF72 repeat expansions was the strongest determinant of FTD (
290              To investigate the mechanism of repeat expansion, we examined the relationship between a
291 yo Clinic Florida in whom the hexanucleotide repeat expansion were found.
292                                   Pathogenic repeat expansions were detected in 45 (37.5%) patients f
293      We conclude that C9ORF72 hexanucleotide repeat expansions were the most frequent mutation in our
294 oinciding with bursts of transposon-mediated repeat expansions, were crucial for the post-Ss4R redipl
295 f DNA mismatch repair involvement in triplet repeat expansion, which encompasses in vitro biochemical
296 tive disorder, caused by a CAG/polyglutamine repeat expansion, which is associated with a dysregulati
297  been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR).
298 e neurodegenerative disorder caused by a CAG repeat expansion within exon 1 of HTT, encoding huntingt
299 enerative disorder caused by an abnormal CAG repeat expansion within exon 1 of the huntingtin gene HT
300                  A pathogenic hexanucleotide repeat expansion within the C9orf72 gene has been identi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top